Novel Tetrazoles against Acanthamoeba castellanii Belonging to the T4 Genotype
暂无分享,去创建一个
Ayaz Anwar | R. Siddiqui | N. Khan | Areeba Anwar | Khalid M. Khan | Itrat Fatima | Yassmin Isse Wehelie | Kanwal Kanwal | Yuh Koon Tong
[1] M. Nessim,et al. Synthesis and characterization of some tetrazoles and their prospective for aerobic micro-fouling mitigation , 2020, Arabian Journal of Chemistry.
[2] M. Khalid,et al. Anti-amoebic potential of azole scaffolds and nanoparticles against pathogenic Acanthamoeba. , 2020, Acta tropica.
[3] Ayaz Anwar,et al. Antiamoebic activity of 3-aryl-6,7-dimethoxyquinazolin-4(3H)-one library against Acanthamoeba castellanii , 2020, Parasitology Research.
[4] Ayaz Anwar,et al. RETRACTED ARTICLE: Antiamoebic activity of synthetic tetrazoles against Acanthamoeba castellanii belonging to T4 genotype and effects of conjugation with silver nanoparticles , 2020, Parasitology Research.
[5] J. McKerrow,et al. The Antifungal Drug Isavuconazole Is both Amebicidal and Cysticidal against Acanthamoeba castellanii , 2020, Antimicrobial Agents and Chemotherapy.
[6] M. Rott,et al. In Vitro Amoebicidal Activity of Imidazolium Salts Against Trophozoites , 2020, Acta Parasitologica.
[7] T. Tunç,et al. Amoebicidal activity of benzothiazole on Acanthamoeba castellanii cysts and trophozoites and its cytotoxic potentials. , 2019, Acta tropica.
[8] Ayaz Anwar,et al. Novel antiacanthamoebic compounds belonging to quinazolinones. , 2019, European journal of medicinal chemistry.
[9] I. Khodadadi,et al. Effect of oxidative stress on vital indicators of Acanthamoeba castellanii (T4 genotype) , 2018, Parasitology Research.
[10] Anoop Kumar,et al. Tetrazoles: Synthesis and Biological Activity , 2018, Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry.
[11] Ayaz Anwar,et al. Silver nanoparticle conjugation affects antiacanthamoebic activities of amphotericin B, nystatin, and fluconazole , 2017, Parasitology Research.
[12] D. Kelly,et al. Azole Antifungal Agents To Treat the Human Pathogens Acanthamoeba castellanii and Acanthamoeba polyphaga through Inhibition of Sterol 14α-Demethylase (CYP51) , 2015, Antimicrobial Agents and Chemotherapy.
[13] M. R. Shah,et al. Photochemotherapeutic Strategy against Acanthamoeba Infections , 2015, Antimicrobial Agents and Chemotherapy.
[14] J. Lorenzo-Morales,et al. An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment , 2015, Parasite.
[15] A. López-Arencibia,et al. Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru , 2013, Parasitology Research.
[16] Naveed Ahmed Khan,et al. Biology and pathogenesis of Acanthamoeba , 2012, Parasites & Vectors.
[17] F. Schuster,et al. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. , 2007, FEMS immunology and medical microbiology.
[18] Naveed Ahmed Khan,et al. Use of In Vitro Assays To Determine Effects of Human Serum on Biological Characteristics of Acanthamoeba castellanii , 2006, Journal of Clinical Microbiology.
[19] J. Piekarczyk,et al. Synthesis and activity of 1H-benzimidazole and 1H-benzotriazole derivatives as inhibitors of Acanthamoeba castellanii. , 2004, Bioorganic & medicinal chemistry.
[20] G. Cabral,et al. Acanthamoeba spp. as Agents of Disease in Humans , 2003, Clinical Microbiology Reviews.
[21] T. Omasa,et al. Synthesis of thiazole derivatives and evaluation of their antiamoebic activity and cytotoxicity. , 2013, Biocontrol science.